Menu

Blog

Sep 21, 2020

Illumina buys Jeff Bezos-backed cancer-testing firm Grail in deal worth $8 billion

Posted by in category: biotech/medical

Gene sequencing company Illumina will pay $8 billion in cash and stock to buy cancer screening startup Grail, the companies said.

Leave a reply